In-office suprachoroidal viscopexy (SCVEXY) shows promise as a novel technique for repairing primary acute rhegmatogenous retinal detachment without the need for incisional surgery, intraocular tamponade, or postoperative positioning. https://t.co/HZHyBBuZPZ https://t.co/mu1fRhNvTa
In-Office Suprachoroidal Viscopexy for Acute Rhegmatogenous Retinal Detachment.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Dec 2024 – Feb 2025Where it's discussed
-
X / Twitter9 posts
-
YouTube2 videos
-
Bluesky1 posts
AI synopsis
What people are saying
The overall sentiment reflects strong agreement and high interest, with posts emphasizing the innovative, less invasive approach, such as 'requires no incisions' and 'promising technique.' The tone and context demonstrate enthusiasm and curiosity about the potential of SCVEXY to improve retinal detachment treatment, indicating a positive outlook on its future impact.
Most discussions recognize the promise of the SCVEXY technique and support its potential benefits, indicating agreement with the publication's findings.
Posts display high interest by highlighting the novelty, minimally-invasive nature, and positive initial outcomes, engaging readers in the topic.
Posts reference specific procedural details and potential clinical advantages, showing moderate depth of engagement with the research.
Discussions emphasize the procedure's potential to influence ophthalmologic practice by offering an office-based, incision-free option, suggesting a moderate impact.
Abstract in brief
- The in-office suprachoroidal viscopexy (SCVEXY) procedure shows promise for treating rhegmatogenous retinal detachment (RRD), with limited available data on its safety and effectiveness.
- A study conducted at St Michael's Hospital from June 2023 to February 2024 followed 6 patients with primary acute RRD to measure outcomes post-SCVEXY treatment.
- Results indicated that 83.3% of patients achieved anatomic reattachment, with no complications and the ability to return to normal activities shortly after the procedure.
Top posts
Most liked on X and BlueskyIn-office suprachoroidal viscopexy (SCVEXY) shows promise as a novel technique for repairing primary acute rhegmatogenous retinal detachment without the need for incisional surgery, intraocular tamponade, or postoperative positioning. https://t.co/fbaZ7Qgm1k https://t.co/vTVJsHzW0c
#眼科文献 上脈絡膜腔への粘弾性物質の注射によって網膜下液を引かせて網膜剥離の治療を行うという手法による症例シリーズ。 https://t.co/5TsV9OlzWk
A St. Michael’s Hospital team that's developed a minimally-invasive technique to repair retinal detachment has published the results of 6 patient cases. The technique, called SCVEXY, requires no incisions and can be performed in office: https://t.co/Pawo1UDhUt
RT @tnishida_: #眼科文献 上脈絡膜腔への粘弾性物質の注射によって網膜下液を引かせて網膜剥離の治療を行うという手法による症例シリーズ。 https://t.co/5TsV9OlzWk
RT @JAMAOphth: In-office suprachoroidal viscopexy (SCVEXY) shows promise as a novel technique for repairing primary acute rhegmatogenous re…
All mentions
Long-term Outcomes and Innovative In-office Repair for Retinal Detachment
Dr. Muni discusses long-term reattachment rates from the PIVOT trial and introduces suprachoroidal viscopexy, an in-office procedure using viscoelastic agents to treat retinal detachment, demonstrating promising results…
Long-Term Outcomes of PIVOT and Suprachoroidal Viscopexy for Retinal Detachment Repair
Dr Muni discusses long-term reattachment rates from the PIVOT trial and introduces the novel in-office Suprachoroidal Viscopexy procedure, showing promising results in retinal detachment treatment with minimal…
RT @JAMAOphth: In-office suprachoroidal viscopexy (SCVEXY) shows promise as a novel technique for repairing primary acute rhegmatogenous re…
RT @JAMAOphth: In-office suprachoroidal viscopexy (SCVEXY) shows promise as a novel technique for repairing primary acute rhegmatogenous re…
In-office suprachoroidal viscopexy (SCVEXY) shows promise as a novel technique for repairing primary acute rhegmatogenous retinal detachment without the need for incisional surgery, intraocular tamponade, or postoperative positioning. https://t.co/fbaZ7Qgm1k https://t.co/vTVJsHzW0c
Ophthopedia Update: In-Office Suprachoroidal Viscopexy for Acute Rhegmatogenous Retinal Detachment: This case series study of 6 patients treated at a single center in Canada reports outcomes with in-office suprachoroidal viscopexy for primary acute rhegmatogenous… #Ophthalmology #Eyecare #JAMA
RT @tnishida_: #眼科文献 上脈絡膜腔への粘弾性物質の注射によって網膜下液を引かせて網膜剥離の治療を行うという手法による症例シリーズ。 https://t.co/5TsV9OlzWk
#眼科文献 上脈絡膜腔への粘弾性物質の注射によって網膜下液を引かせて網膜剥離の治療を行うという手法による症例シリーズ。 https://t.co/5TsV9OlzWk
RT @JAMAOphth: In-office suprachoroidal viscopexy (SCVEXY) shows promise as a novel technique for repairing primary acute rhegmatogenous re…
RT @JAMAOphth: In-office suprachoroidal viscopexy (SCVEXY) shows promise as a novel technique for repairing primary acute rhegmatogenous re…
A St. Michael’s Hospital team that's developed a minimally-invasive technique to repair retinal detachment has published the results of 6 patient cases. The technique, called SCVEXY, requires no incisions and can be performed in office: https://t.co/Pawo1UDhUt
In-office suprachoroidal viscopexy (SCVEXY) shows promise as a novel technique for repairing primary acute rhegmatogenous retinal detachment without the need for incisional surgery, intraocular tamponade, or postoperative positioning. https://t.co/HZHyBBuZPZ https://t.co/mu1fRhNvTa